U.S. federal trademark · Serial No. 86707099 · Reg. No. 5302024
Pharmaceutical preparations for the treatment of tuberculosis, leishmaniasis, malaria, leprosy, pandemic flu and HIV; vaccines; adjuvants for use with vaccines; biologic formulations, diagnostic agents and pharmaceutical preparations, namely, drug delivery agents comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents for use in connection with humans and animals for the treatment of tuberculosis, leishmaniasis, malaria, leprosy, pandemic flu and HIV
Medical and scientific research in the fields of vaccines, pharmaceuticals, biologics, vaccines, adjuvants, adjuvant formulations, biologic formulations, drug delivery, diagnostics, and medical therapeutics; product research and development in the fields of pharmaceuticals, vaccines, diagnostics, adjuvants, adjuvant formulations, biologic formulations and drug delivery
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.